Gonorrhea



Use of a Rapid Turnaround Test for NG/CT to Improve Treatment of Women Presenting With Possible STIs


Conditions:   Sexually Transmitted Infection;   Gonorrhea Female;   Chlamydia Females
Interventions:   Device: Cepheid Xpert CT/NG Rapid Turnaround Test;   Device: Polymerase chain reaction (PCR)
Sponsor:   University of Maryland
Not yet recruiting - verified March 2017


Check it: A New Approach to Controlling Chlamydia Transmission in Young People


Conditions:   Chlamydia Trachomatis Infection;   Gonorrhea
Intervention:   Other: Ct/GC screening
Sponsors:   Tulane University;   National Institutes of Health (NIH);   Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
Not yet recruiting - verified April 2017


MAMAS: Mentoring Adolescent Mothers at School


Conditions:   Human Immunodeficiency Virus;   Herpes Simplex Type II;   Chlamydia;   Gonorrhea;   Trichomonas Vaginitis
Intervention:   Behavioral: Mentoring Adolescent Mothers at School (MAMAS)
Sponsors:   Drexel University;   University of KwaZulu;   University of North Carolina, Chapel Hill
Not yet recruiting - verified May 2017


Evaluation of the Atlas Genetics io® CTNG System


Conditions:   Chlamydia Trachomatis;   Gonorrhea
Intervention:   Device: Atlas Genetics io® system
Sponsor:   Atlas Genetics Limited
Recruiting - verified May 2017


Screening of Gonococcal and Chlamydial Infections in the Third Trimester


Conditions:   Gonococcal Infection;   Chlamydia Infections
Intervention:  
Sponsor:   St. Michael's Hospital, Toronto
Enrolling by invitation - verified March 2017


STI Screening as a Combined HIV Prevention Platform for MSM in Peru


Conditions:   Gonorrhoea of Rectum;   Chlamydia of Rectum;   HIV Infections
Interventions:   Behavioral: PCC;   Behavioral: Traditional Counseling
Sponsors:   University of California, Los Angeles;   NGO Via Libre;   University of California, San Francisco
Not yet recruiting - verified May 2017


Clinical Validation of a Molecular Test for Ciprofloxacin-Susceptibility in Neisseria Gonorrheaoe


Condition:   Gonorrhoea
Intervention:   Drug: Ciprofloxacin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 11, 2017


Performance of Nucleic Acid Amplification Tests for the Detection of NG and CT


Conditions:   Neisseria Gonorrhoeae Infection;   Chlamydia Trachomatis Infection;   Sexually Transmitted Diseases
Interventions:   Device: NAAT 1 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 2 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 3 to Detect Rectal and Pharyngeal NG and CT;   Device: NAAT 4 to Detect Rectal and Pharyngeal NG;   Device: NAAT 4 to Detect Rectal and Pharyngeal CT
Sponsors:   Duke University;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified April 2017


Clinical Evaluation of the Aptima® Combo 2® Assay Using the Panther® System in Female Urine Samples


Conditions:   Chlamydia Trachomatis;   Gonorrhea
Intervention:  
Sponsor:   Hologic, Inc.
Terminated - verified March 2017


Cefixime / Azithromycin pK Study


Condition:   Gonorrhoea
Interventions:   Drug: Azithromycin;   Drug: Cefixime
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Active, not recruiting - verified December 7, 2016


Texting Intervention to Sustain HIV Prevention in Women in High-drug-use Contexts


Conditions:   HIV;   Syphilis;   Gonorrhea;   Chlamydia
Interventions:   Behavioral: Mujer Segura Siempre;   Behavioral: General Health Message Texts
Sponsors:   University of California, San Diego;   Comisión de Salud Fronteriza México-Estados Unidos (CSFMEU)
Active, not recruiting - verified May 2017


Multimedia WORTH With Black Drug-Involved Women on Probation


Conditions:   Sexually Transmitted Infections;   HIV;   Gonorrhea;   Trichomonas;   Chlamydia Trachomatis;   Drug Use
Interventions:   Behavioral: E-WORTH;   Behavioral: Streamlined HIV Testing
Sponsors:   Columbia University;   Fortune Society;   University of Pennsylvania;   State University of New York - Downstate Medical Center;   RTI International;   Duke University;   National Institute on Drug Abuse (NIDA)
Recruiting - verified August 2016


Genitourinary and Pharyngeal Pharmacokinetics of Solithromycin


Condition:   Gonorrhoea
Intervention:   Drug: Solithromycin
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified April 5, 2017


Rapid Diagnosis of Antibiotic Resistance in Gonorrhoea


Condition:   Gonorrhoea
Intervention:  
Sponsor:   University of Bern
Completed - verified September 2016


Emergency Department, Rapid Assessment for Sexually Transmitted Infection


Condition:   Infection
Intervention:  
Sponsors:   Henry Ford Health System;   Cepheid
Completed - verified January 2017


A Dose-Ranging Study Evaluating the Efficacy, Safety, and Tolerability of GSK2140944 in the Treatment of Uncomplicated Urogenital Gonorrhea Caused by Neisseria Gonorrhoeae


Condition:   Gonorrhea
Intervention:   Drug: GSK2140944
Sponsor:   GlaxoSmithKline
Completed - verified February 2017


Randomized, Open-label Phase 2 Study of Oral AZD0914 in the Treatment of Gonorrhea


Condition:   Gonorrhoea
Interventions:   Drug: AZD0914;   Drug: Ceftriaxone
Sponsor:   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified January 5, 2016


Efficacy and Safety Study of Oral Solithromycin Compared to Intramuscular Ceftriaxone Plus Oral Azithromycin in the Treatment of Patients With Gonorrhea


Condition:   Uncomplicated Urogenital Gonorrhea
Interventions:   Drug: solithromycin;   Drug: ceftriaxone;   Drug: azithromycin
Sponsors:   Cempra Inc;   National Institute of Allergy and Infectious Diseases (NIAID)
Recruiting - verified September 2016


Implementation of a Sexual Health Intervention for Young Men Who Have Sex With Men (MSM) in Two Vietnamese Cities


Conditions:   HIV;   Chlamydia;   Gonorrhea;   Syphilis;   Hepatitis C
Intervention:   Behavioral: Sexual Health Promotion Intervention
Sponsors:   National Development and Research Institutes, Inc.;   National Institute on Drug Abuse (NIDA);   Hanoi Medical University;   University of Puerto Rico
Completed - verified October 2015


Detection of Chlamydia (CT) and Gonorrhea (NG)


Conditions:   Chlamydia;   Gonorrhea
Intervention:   Device: illumigene CT and NG assays, illumipro-10
Sponsor:   Meridian Bioscience, Inc.
Unknown status - verified September 2014


Evaluation of Immediate v. Delayed CT/NG Test for Treatment in the ED


Condition:   Reproductive Tract Infections
Interventions:   Device: Roche AMPLICOR CT/NG;   Device: Cepheid Xpert CT/NG Test
Sponsors:   George Washington University;   Cepheid
Completed - verified November 2013


Self-Obtained Vaginal Swabs for Chlamydia and Gonorrhea Testing


Conditions:   Chlamydial Infection;   Gonococcal Infection
Intervention:  
Sponsors:   University of California, San Francisco;   University of Alabama at Birmingham
Completed - verified June 2016


Keep It Up! 2.0: A Comparison of Two Online HIV Intervention Programs for Young Men Who Have Sex With Men


Conditions:   HIV;   Gonorrhea;   Chlamydia
Interventions:   Behavioral: Keep It Up!;   Behavioral: HIV Knowledge Control
Sponsors:   Northwestern University;   National Institute on Drug Abuse (NIDA);   Emory University;   Hunter College of City University of New York
Active, not recruiting - verified January 2017


Safety and Efficacy Study of Single-Dose Oral CEM-101 in Patients With Uncomplicated Urogenital Gonorrhea


Condition:   Uncomplicated Urogenital Gonorrhea
Interventions:   Drug: solithromycin;   Drug: Solithromycin (CEM-101)
Sponsor:   Cempra Inc
Completed - verified March 2017


A Validation Study for Detecting Chlamydia and Gonorrhea in Rectal Samples


Conditions:   Gonorrhea;   Chlamydia
Intervention:   Other: Gen-Probe APTIMA Combo2 (AC2)
Sponsors:   University of Pittsburgh;   National Institutes of Health (NIH);   National Institute of Allergy and Infectious Diseases (NIAID)
Completed - verified August 2016

Refine Your Search Advanced Search